To use this feature, join Babbler easily !
Babbler allows PR people and reporters to collaborate a better way.
By joining Babbler you will be able to access hundreds of newsrooms and PR contacts from your industrie(s) and also share with them your upcoming needs.
Their newsrooms are already on Babbler
You're 1 click away from signing up
Nice to see you again !
Alopecia Market Scope By Disease Type, End Use, Sales Channel, Gender, Region And Forecast Till 2026: Grand View Research Inc.
minutes reading time
minute reading time
San Francisco, January 28, 2020: The Report Alopecia Market Size, Share & Trends Analysis Report By Disease Type, By End Use (Homecare Settings, Dermatology Clinics), By Sales Channel (OTC, Prescription), By Gender, And Segment Forecasts, 2019 - 2026
The global alopecia market size is anticipated to reach USD 4.8 billion by 2026, according to a report published by Grand View Research, Inc., registering an 8.3% CAGR during the forecast period. The market is expected to be driven by increase in disease prevalence, technological advancements, and rise in per-capita healthcare expenditures across the globe.
The disease prevalence is increasing due to changing lifestyle patterns, such as increased consumption of alcohol and tobacco, changing food habits, high level of stress, and rising geriatric population. These factors are expected to boost the market over the forecast period. In addition, rising incidences of chronic diseases such as Polycystic Ovary Syndrome (PCOS), cancer, and rheumatoid arthritis are likely to fuel market growth.
Statistics presented by the National Alopecia Areata Foundation states that 147 million people worldwide, including 6.8 million people in US alone, are affected by alopecia areata. Growing patient awareness about the disease and its treatment is anticipated to contribute to alopecia market growth. For instance, the Treatment Development Program (TDP) by National Alopecia Areata Foundation has resulted in an increase in research studies pertaining to this condition.
Currently, there are two FDA-approved therapeutics for the condition-Rogaine and Propecia. Generic penetration has significantly increased, following patent expirations of both drugs. However, impending launch of several promising pipeline candidates, such as Jakafi (ruxolitinib), Xeljanz (tofacitinib), Breezula (clascoterone), Lumigan (Bimatoprost), and SM04554 is expected to significantly drive the market in the near future.
Reimbursement coverage for treatment of this medical condition is one of the major challenges in this therapeutic landscape. Since most treatment modalities for this condition are considered cosmetic procedures and not medically essential, they are generally not covered under insurance. Out-of-pocket costs for this disease treatment usually include frequent doctor visits, prescription drug copays, and coinsurance for procedures.
Access Research Report of Alopecia Market @ https://www.grandviewresearch.com/industry-analysis/alopecia-market
Further key findings from the study suggest:
- High disease prevalence due to changing lifestyle patterns is the main factor driving the alopecia market
- Globally, lack of reimbursement policies will continue to restrain growth
- By disease type, alopecia areata accounted for more than 30.0% of the revenue in 2018
- Androgenetic alopecia, on the other hand, is expected to exhibit a CAGR of over 10.0% through 2026
- Homecare end-use settings are likely to be driven by increasing availability of OTC products and patient convenience
- Geographically, Asia Pacific is expected to demonstrate the fastest regional growth
Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the global alopecia market on the basis of disease type, end use, sales channel, gender, and region:
Alopecia Disease Type Outlook (Revenue, USD Million, 2014 - 2026)
- Alopecia Areata
- Alopecia scar
- Alopecia traction
- Alopecia Totalis
- Alopecia Universalis
- Androgenetic Alopecia
Alopecia End-use Outlook (Revenue, USD Million, 2014 - 2026)
- Homecare Settings
- Dermatology Clinics
Alopecia Sales Channel Outlook (Revenue, USD Million, 2014 - 2026)
Alopecia Gender Outlook (Revenue, USD Million, 2014 - 2026)
Alopecia Regional Outlook (Revenue, USD Million, 2014 - 2026)
- North america
- Asia Pacific
- Latin america
Access Press Release of Alopecia Market @ https://www.grandviewresearch.com/press-release/global-alopecia-market
About Grand View Research
Grand View Research, Inc. is a US based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
Congratulations, you're registered on Babbler!
Discover now all the news waiting for you on Babbler: visit your newsfeed.!
Your topics have been selected, you can change it by clicking here